Amazon Web Services and Gilead Work Together to Develop and Deliver New Medicines for Patients | Financial Buzz

Amazon Web Services and Gilead Work Together to Develop and Deliver New Medicines for Patients, Inc. (NASDAQ: AMZN) company, Amazon Web Services Inc. and Gilead Services, Inc. (NASDAQ: GILD) have selected AWS as preferred cloud provider.  Gilead will utilize AWS to provide its data scientist with the latest advances in machine learning and analytics.  This will fuel data-driven decision making across the company ranging from biomarker discovery through manufacturing to clinical trial recruit and deliver insights that will aide Gilead in refining its drug pipeline.  “With AWS as our preferred cloud provider, our researchers can use AWS’s portfolio of services to gain the insights, agility, and security needed to deliver new medicines at speed, and treat the individual according to their unique needs, not just the disease,” said Marc Berson, Senior Vice President and Chief Information Officer at Gilead. “AWS’s performance, infrastructure, and scale are the foundations on which we will complete our ERP transformation and become a more efficient, agile, secure, and data-driven business in the cloud.”

“Gilead uses the proven performance of the world’s leading cloud to innovate, scale, and deliver powerful therapies for diseases like HIV and cancer, as well as advance standards for precision medicine. By streamlining their IT operations with AWS and taking advantage of our AWS for Health offerings, Gilead has the ability to continuously refine its approach to clinical trials, drug development, manufacturing, and distribution,” said Matt Garman, Senior Vice President of Sales and Marketing at Amazon Web Services, Inc. “AWS provides the security and privacy that healthcare and life sciences companies need, as well as the expertise and breadth and depth of services they can rely on to build transformative healthcare solutions that enhance health and wellbeing.”

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!